EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Autoantibodies to Disease‐Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis

Erik Lönnblom, Monica Leu Agelii iD, Outi Sareila iD, Lei Cheng, Bingze Xu, Johan Viljanen, Ingiäld Hafström, Maria L E Andersson iD, Göran Bergström, Anna-Karin Hultgård Ekwall, Anna Rudin, Alf Kastbom iD und 5 weitere

Arthritis & Rheumatology · 2023-07 · 75 (7) · 1110-1119

DOI: 10.1002/art.42463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 27.04.2023. Verfasst von Erik Lönnblom und 16 weiteren Autor:innen. Beteiligte Einrichtung: Section of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Arthritis, Rheumatoid, Osteoarthritis, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Research Council, Knut och Alice Wallenbergs Stiftelse, Swedish Rheumatism Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to develop and characterize a multiplex immunoassay for detection of autoantibodies against peptides derived from proteins known to play a role in development of arthritis and that are also expressed in joints.

Methods

We selected peptides from the human counterpart of proteins expressed in the joints, based on mouse models that showed these to be targeted by pathogenic or regulatory antibodies in vivo. Using bead‐based flow immunoassays measuring IgG antibodies, we selected triple helical or cyclic peptides, containing the epitopes, to avoid collinear reactivity. We characterized the analytical performance of the immunoassay and then validated it in 3 independent rheumatoid arthritis (RA) cohorts (n = 2,110), Swedish age‐ and sex‐matched healthy controls, and patients with osteoarthritis (OA), patients with psoriatic arthritis (PsA), and patients with systemic lupus erythematosus (SLE).

Results

Screening assays showed 5 peptide antigens that discriminated RA patients from healthy controls with 99% specificity (95% confidence interval [CI] 98–100%). In our validation studies, we reproduced the discriminatory capacity of the autoantibodies in 2 other RA cohorts, showing that the autoantibodies had high discriminatory capacity for RA versus OA, PsA, and SLE. The novel biomarkers identified 22.5% (95% CI 19–26%) of early RA patients seronegative for anti–cyclic citrullinated peptide and rheumatoid factor. The usefulness of the biomarkers in identifying seronegative RA patients was confirmed in validation studies using 2 independent cohorts of RA patients and cohorts of patients with OA, PsA, and SLE.

Conclusion

A multiplex immunoassay with peptides from disease‐related proteins in joints was found to be useful for detection of specific autoantibodies in RA serum. Of note, this immunoassay had high discriminatory capacity for early seronegative RA. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticArthritis, RheumatoidOsteoarthritisLupus Erythematosus, SystemicAnimalsMiceHumansAutoantibodiesPeptides, CyclicPeptidesBiomarkers

Substanzen

AutoantibodiesPeptides, CyclicPeptidesBiomarkers

Autor:innen und Institutionen

  • Section of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Section of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, and Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgre…
  • Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden.
  • Department of Division of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, and Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden.
  • Spenshult Research and Development Center, Halmstad, and Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden.

ORCID-Profile: Monica Leu Agelii, Outi Sareila, Maria L E Andersson, Alf Kastbom, Christopher Sjöwall, Inger Gjertsson

Förderung

  • Swedish Research Council
  • Knut och Alice Wallenbergs Stiftelse
  • Swedish Rheumatism Association
  • Foundation for Assistance to Disabled People in Skane

Zitieren

APA

Lönnblom, E., Leu Agelii, M., Sareila, O., Cheng, L., Xu, B., Viljanen, J., Hafström, I., Andersson, M. L. E., Bergström, G., Hultgård Ekwall, A. K., Rudin, A., Kastbom, A., Sjöwall, C., Jacobsson, L. T. H., Kihlberg, J., Gjertsson, I., & Holmdahl, R. (2023). Autoantibodies to Disease‐Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis. Arthritis & Rheumatology, 75(7), 1110-1119. https://doi.org/10.1002/art.42463

Vancouver

Lönnblom E, Leu Agelii M, Sareila O, Cheng L, Xu B, Viljanen J, et al. Autoantibodies to Disease‐Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis. Arthritis & Rheumatology. 2023;75(7):1110-1119. doi:10.1002/art.42463

BibTeX
@article{Lnnblom2023,
  author = {Lönnblom, Erik and Leu Agelii, Monica and Sareila, Outi and Cheng, Lei and Xu, Bingze and Viljanen, Johan and Hafström, Ingiäld and Andersson, Maria L E and Bergström, Göran and Hultgård Ekwall, Anna-Karin and Rudin, Anna and Kastbom, Alf and Sjöwall, Christopher and Jacobsson, Lennart T H and Kihlberg, Jan and Gjertsson, Inger and Holmdahl, Rikard},
  title = {Autoantibodies to Disease‐Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  volume = {75},
  number = {7},
  pages = {1110--1119},
  doi = {10.1002/art.42463}
}
Kostenlos starten →